119 related articles for article (PubMed ID: 16276122)
1. Functional interaction of a beta-adrenergic agonist and cyclic GMP phosphodiesterase inhibitor in control and hypertrophic cardiomyocytes.
Zhang S; Rodriguez R; Scholz PM; Weiss HR
Pharmacology; 2006; 76(2):53-60. PubMed ID: 16276122
[TBL] [Abstract][Full Text] [Related]
2. Negative inotropic effects of C-type natriuretic peptide are attenuated in hypertrophied ventricular myocytes associated with reduced cyclic GMP production.
Moalem J; Davidov T; Zhang Q; Grover GJ; Weiss HR; Scholz PM
J Surg Res; 2006 Sep; 135(1):38-44. PubMed ID: 16600302
[TBL] [Abstract][Full Text] [Related]
3. Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterases.
Weiss HR; Gong GX; Straznicka M; Yan L; Tse J; Scholz PM
Can J Physiol Pharmacol; 1999 Jun; 77(6):422-31. PubMed ID: 10537228
[TBL] [Abstract][Full Text] [Related]
4. Interaction between the opposing functional effects of cyclic AMP and cyclic GMP in hypertrophic cardiac myocytes.
Patel KN; Yan L; Gandhi A; Scholz PM; Weiss HR
Basic Res Cardiol; 2001 Feb; 96(1):34-41. PubMed ID: 11215530
[TBL] [Abstract][Full Text] [Related]
5. Negative functional effects of natriuretic peptides are attenuated in hypertrophic cardiac myocytes by reduced particulate guanylyl cyclase activity.
Meyer M; Zhang Q; Khurana K; Scholz PM; Weiss HR
J Cardiovasc Pharmacol; 2007 Feb; 49(2):100-5. PubMed ID: 17312451
[TBL] [Abstract][Full Text] [Related]
6. Cyclic GMP protein kinase mediates negative metabolic and functional effects of cyclic GMP in control and hypertrophied rabbit cardiac myocytes.
Straznicka M; Gong G; Yan L; Scholz PM; Weiss HR
J Cardiovasc Pharmacol; 1999 Aug; 34(2):229-36. PubMed ID: 10445674
[TBL] [Abstract][Full Text] [Related]
7. Altered relationship between cyclic GMP and myocardial O2 consumption in renal hypertension-induced cardiac hypertrophy.
Rabindranauth P; Scholz PM; Tse J; Naim KL; Weiss HR
Res Exp Med (Berl); 1998 Jul; 198(1):11-21. PubMed ID: 9706666
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
Ebihara Y; Karmazyn M
Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
[TBL] [Abstract][Full Text] [Related]
9. Effect of increased myocardial cyclic GMP induced by cyclic GMP-phosphodiesterase inhibition on oxygen consumption and supply of rabbit hearts.
Weiss HR; Rodriguez E; Tse J; Scholz PM
Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):607-14. PubMed ID: 7813120
[TBL] [Abstract][Full Text] [Related]
10. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
[TBL] [Abstract][Full Text] [Related]
11. Cyclic GMP-dependent protein kinase activation in the absence of negative inotropic effects in the rat ventricle.
MacDonell KL; Diamond J
Br J Pharmacol; 1997 Dec; 122(7):1425-35. PubMed ID: 9421291
[TBL] [Abstract][Full Text] [Related]
12. Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat.
Wegener JW; Gath I; Förstermann U; Nawrath H
Br J Pharmacol; 1997 Dec; 122(7):1523-9. PubMed ID: 9421305
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cyclic GMP hydrolysis with zaprinast reduces basal and cyclic AMP-elevated L-type calcium current in guinea-pig ventricular myocytes.
Ziolo MT; Lewandowski SJ; Smith JM; Romano FD; Wahler GM
Br J Pharmacol; 2003 Mar; 138(5):986-94. PubMed ID: 12642401
[TBL] [Abstract][Full Text] [Related]
14. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
[TBL] [Abstract][Full Text] [Related]
15. Selective phosphodiesterase inhibition and alterations of cardiac function by alkylated xanthines.
Mushlin P; Boerth RC; Wells JN
Mol Pharmacol; 1981 Jul; 20(1):179-89. PubMed ID: 6270531
[No Abstract] [Full Text] [Related]
16. Importance of ryanodine receptors in effects of cyclic GMP is reduced in thyroxine-induced cardiac hypertrophy.
Zhang Q; Goel N; Rodriguez R; Scholz PM; Weiss HR
Eur J Pharmacol; 2006 May; 537(1-3):45-51. PubMed ID: 16626695
[TBL] [Abstract][Full Text] [Related]
17. Decreasing cyclic GMP exerts similar positive functional effects on cardiac myocytes regardless of initial level.
Yan L; Huang MW; Scholz PM; Weiss HR
Pharmacology; 2000 Jul; 61(1):51-6. PubMed ID: 10895081
[TBL] [Abstract][Full Text] [Related]
18. Basal muscarinic activity does not impede beta-adrenergic activation in rabbit hearts in controls or thyroxine-induced cardiac hypertrophy.
Naim KL; Rabindranauth P; Scholz PM; Tse J; Weiss HR
J Cardiovasc Pharmacol; 1997 Oct; 30(4):405-11. PubMed ID: 9335397
[TBL] [Abstract][Full Text] [Related]
19. Effects of triiodothyronine pretreatment on beta-adrenergic responses in stunned cardiac myocytes.
Tse J; Gandhi A; Yan L; He YQ; Weiss HR
J Cardiothorac Vasc Anesth; 2003 Aug; 17(4):486-90. PubMed ID: 12968237
[TBL] [Abstract][Full Text] [Related]
20. Pertussis toxin-sensitive G protein but not NO/cGMP pathway mediates the negative inotropic effect of carbachol in adult rat cardiomyocytes.
Sandirasegarane L; Diamond J
Pharmacology; 2004 Jan; 70(1):46-56. PubMed ID: 14646356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]